Rare Tumours in Children and Adolescents (STEP)

Recruiting

• Conditions: Rare Diseases
• Interventions: Other: Data collection

• Registration Number: NCT05773651
• Lead Sponsor: University Hospital Tuebingen

Brief Summary

The aim of the STEP registry is to collect and evaluate experience and data on the diagnosis and treatment of rare childhood tumors in order to use the knowledge gained to improve the treatment prospects for our patients. The rarity of a disease should not be a disadvantage for the young patients.

Detailed Description

The objective of the STEP registry is to optimise the diagnosis and treatment of patients with rare tumour diseases in childhood and adolescence. Therefore, a continuous prospective collection of clinical data on rare paediatric tumours is conducted to improve the understanding of these tumours. Beyond analysis of clinical data, further scientific research on the biological and molecular genetic characteristics of these tumours is performed. These data and a close collaboration with international partners, especially the European EXPeRT group, enable the improvement of treatment recommendations for these tumours along with establishment a global interdisciplinary network of rare tumour specialists.

Study Timeline

• Study Start: 2023-01-11
• Study First Submitted: 2023-03-06
• Study First Submitted QC: 2023-03-06
• Study First Posted: 2023-03-17
• Status Verified: 2024-09
• Last Update Submitted: 2024-09-27
• Last Update Posted: 2024-09-30
• Primary Completion: 2050-01
• Study Completion: 2055-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Diagnosis of a rare solid tumor
• Age at diagnosis: Neonatal period to 18 years (In the case of young adults, registration in the database and/or referral to advisory contact persons within the framework of the competence network can take place upon request and after declaration of consent.)
• Information, education, written consent of the patient or the guardian
• Not recorded in any of the existing clinical studies/ registers of the German Society for Pediatric Oncology and Hematology (GPOH)

Exclusion Criteria

• Registration of the tumor diagnosis in a prospective therapy study/ another clinical registry of the GPOH
• Lack of information, explanation and/or written consent of the patient or the legal guardian.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Rare tumor disease	Data collection	Prospective epidemiological and clinical data collection of subjects with diagnosis of a rare solid tumor.

Primary Outcome Measures

Name	Time	Method
Event-free survival	5 years	Period between study entry and failure of induction therapy, recurrence or death from any cause is measured.

Trial Locations

Locations (1)

University Hospital Tübingen; 🇩🇪 Tübingen, Germany